secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001104659-25-075194
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health Q2 revenue $654.8M, +35% YoY; adjusted EBITDA $48.1M, guidance reiterated
--------------------------------------------------------------------------------

- Total revenue $654.8M, up 35% from $486.3M; adjusted EBITDA $48.1M, both at higher end of guidance.
- Net income $9.4M, EPS-diluted $0.19; six-month EPS $0.33.
- Care Partners revenue $631.4M, up 36% YoY.
- Reiterates full-year 2025 guidance, inclusive of completed Prospect Health acquisition.
- Medical cost trends within expectations across all lines of business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925075194/0001104659-25-075194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925075194/tm2521330d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-075194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer